Arriva Medical has applauded a district court's decision to deny a motion from Centers for Medicare & Medicaid Services (CMS) to dismiss Arriva’s complaint while expressing disappointment that it denied Arriva's motion for interim relief.
Merck and Pfizer Inc. said the U.S. Food and Drug Administration (FDA) has agreed to review three New Drug Applications for medications containing ertugliflozin that treat glycemic control in adults with type 2 diabetes.
The Department of Health and Human Services has updated the National Viral Hepatitis Action Plan to include new indicators to measure the success of treatment and eventual elimination of the virus between 2017 and 2020.
A recent SEARCH for Diabetes in Youth study found that teens and young adults with Type 2 diabetes are more likely to develop complications in the years following their diagnosis than their peers with Type 1 diabetes.
The Pharmaceutical Research and Manufacturers of American recently hosted the “Through the Microscope: Examining Modern Medicine” national health care discussion series sponsored as part of the new GOBOLDLY campaign.
A panel of health experts met recently at Duke-Raleigh Hospital to discuss the potential impact of county and municipal bans on smoking in North Carolina, America's largest tobacco-producing state, the Cancer Action Network reported.
The American Academy of Family Physicians joined more than 350 organizations in penning a recent letter to President Donald Trump asking for support in spreading the importance and safety of vaccinations.
The Centers for Disease Control, American Academy of Family Physicians (AAFP) and several other medical groups have released the 2017 adult and childhood immunization schedules with their latest recommendations.